Pharmafile Logo

Mallinckrodt

- PMLiVE

Mallinckrodt cuts $5.6bn deal to buy Questcor

Irish company continues move from medical imaging to pharma products

Mallinckrodt offers $1.3bn for Cadence Pharma

Deal would include injectable painkiller Ofirmev

FDA grants priority review to pain drug

Mallinckrodt’s MNK-795 is intended for the management of moderate to severe acute pain

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links